Report: EU IVDR State of the Industry 2021
May 23, 2022
MedTech Summit and NSF conducted a huge survey of medical device and IVD professionals to discover the industry’s readiness for the IVDR.
In June 2021, NSF partnered with Informa to launch a huge industry survey on how prepared organizations were just under a year until the IVDR date of application.
The survey asked questions around the impacts of the global COVID-19 pandemic, the industry’s readiness to meet the IVDR requirements, whether notified bodies have the capacity and time to handle all conformity assessments heading their way, changes to PMS and clinical requirements, and confidence in the resources manufacturers have to maintain compliance once their CE marks are approved.
Key insights from the survey:
- Only 15% of organizations are fully prepared to hit the IVDR deadline of May 26, 2022
- 55% want more guidance from the European Commission and/or the MDCG
- 38% are planning to transfer their IVD product portfolio to IVDR
- 21% currently have an IVDR-certified product
- 95% say the COVID-19 pandemic has impacted their IVDR implementation
How NSF Can Help You
Get in touch to find out how we can help you and your business thrive.
What’s New with NSF
NSF Annual Review and Impact Report 2025 Now Live
April 20, 2026NSF has published its Annual Review and Impact Report 2025, detailing the organization’s progress over the past year and outlining strategic priorities for 2026.
Visit NSF at Making Pharma 2026
April 10, 2026Connect with our experts to discover how we help leading pharmaceutical and biotechnology companies achieve regulatory compliance and operational excellence.